{'text': 'Sanofi Receives FDA Approval of Priftin® (rifapentine) Tablets for the Treatment of Latent Tuberculosis Infection', 'publisher': {'href': 'https://www.3blmedia.com', 'title': '3BL Media'}, 'created_at': 'Mon, 08 Dec 2014 08:00:00 GMT', 'description': 'Sanofi Receives FDA Approval of Priftin® (rifapentine) Tablets for the Treatment of Latent Tuberculosis Infection  3BL Media', 'url': 'https://news.google.com/rss/articles/CBMiuAFBVV95cUxPWUR6enBFTnRWdmRJNFJvZDlSWWpnM3UzYndrQWgyTWx5OUw2Z0tlcDVTbGQzenhYTy1TNVVhX0xUc3dyZThyQmF5V2J2UjBBei11OXd4emJ6WV9ObERVSnFaSEJkT2s2aWZhZVM5OFRPdHlRR1dJUF93NGg3UUZjUXRKWTdYZEs2dzZ5VlFLTnU3WV95V3U1Ry10WHJlVDdlMzBwVjdra3U1eDBnaUdTTkRaRXhzY0xV?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Patients to influence voice of Lemtrada consumer campaign', 'publisher': {'href': 'https://www.mmm-online.com', 'title': 'MM+M Online'}, 'created_at': 'Tue, 09 Dec 2014 08:00:00 GMT', 'description': 'Patients to influence voice of Lemtrada consumer campaign  MM+M Online', 'url': 'https://news.google.com/rss/articles/CBMiswFBVV95cUxOLU96bHpYMWdZZklhaFpUN3V2TzFLdHdXSGR5TU1mMjcyTm9RQTc0VTY4RXpOZGowZDNyWENHcG1qYUpkRkJCT1pDbHRlM3ZhU3FxcHpwTHZRaElfTHVrVW1TcWdjVGpzSGlzSS1VTzFiQWtjSnhDc3RaR1JqVEJDMjFyM0stN05vcUs1blFKRnhXOTlrMVhoZlBzVnBWbmRMbExNeFk5U3dfd09VM0VQTDR0MA?oc=5&hl=en-US&gl=US&ceid=US:en'}
